Maryland will become the first state with a drug affordability review board, which will study prescription costs paid by state and local governments and make policy recommendations, when a new law goes into effect on July 1.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,